Difference between revisions of "Team:Stony Brook/Collaborations"

 
(One intermediate revision by one other user not shown)
Line 240: Line 240:
 
<p>Figure 21: Comparison of people’s answers to the questions “How do you feel about the impact of synthetic biology?” versus “How do you feel about the impact of GMOs?”
 
<p>Figure 21: Comparison of people’s answers to the questions “How do you feel about the impact of synthetic biology?” versus “How do you feel about the impact of GMOs?”
 
</p>
 
</p>
<div style="text-align: center"><img src="https://static.igem.org/mediawiki/2017/a/a0/T--Stony_Brook--collabn-21.png" style="text-align: center;width:650;height:470px;"/></div>
+
<div style="text-align: center"><img src="https://static.igem.org/mediawiki/2017/a/a0/T--Stony_Brook--collabn-21.png" style="text-align: center;width:550px;height:398px;"/></div>
  
 
<br />
 
<br />
Line 247: Line 247:
 
<p>Figure 22: Comparison between people's answers to the use of synthetic biology products versus their trust of companies handling synthetic biology related products
 
<p>Figure 22: Comparison between people's answers to the use of synthetic biology products versus their trust of companies handling synthetic biology related products
 
</p>
 
</p>
<div style="text-align: center"><img src="https://static.igem.org/mediawiki/2017/f/f0/T--Stony_Brook--collabn-22.png" style="text-align: center;width:650px;height:433px;"/></div>
+
<div style="text-align: center"><img src="https://static.igem.org/mediawiki/2017/f/f0/T--Stony_Brook--collabn-22.png" style="text-align: center;width:550px;height:367px;"/></div>
  
 
<br />
 
<br />
Line 254: Line 254:
 
<p>Figure 23: Comparison between people's views on the labeling of synthetic biology products versus their trust of companies handling synthetic biology related products
 
<p>Figure 23: Comparison between people's views on the labeling of synthetic biology products versus their trust of companies handling synthetic biology related products
 
</p>
 
</p>
<div style="text-align: center"><img src="https://static.igem.org/mediawiki/2017/e/ec/T--Stony_Brook--collabn-23.png" style="text-align: center;width:650px;height:497px;"/></div>
+
<div style="text-align: center"><img src="https://static.igem.org/mediawiki/2017/e/ec/T--Stony_Brook--collabn-23.png" style="text-align: center;width:550px;height:421px;"/></div>
  
 
<br />
 
<br />
Line 260: Line 260:
  
 
<p>Figures 24 and 25: Statistical measures of the categories of the perception of synthetic biology, and the correlation between each category.</p>
 
<p>Figures 24 and 25: Statistical measures of the categories of the perception of synthetic biology, and the correlation between each category.</p>
<div style="text-align: center"><img src="https://static.igem.org/mediawiki/2017/8/8c/T--Stony_Brook--collab-11.png" style="text-align: center;width:550px;height:127px;"/></div>
+
<div style="text-align: center"><img src="https://static.igem.org/mediawiki/2017/8/8c/T--Stony_Brook--collab-11.png" style="text-align: center;width:600px;height:139px;"/></div>
<div style="text-align: center"><img src="https://static.igem.org/mediawiki/2017/c/cd/T--Stony_Brook--collab-12.png" style="text-align: center;width:600px;height:131px;"/></div>
+
<div style="text-align: center"><img src="https://static.igem.org/mediawiki/2017/c/cd/T--Stony_Brook--collab-12.png" style="text-align: center;width:600px;height:157px;"/></div>
  
 
<br />
 
<br />
Line 268: Line 268:
  
 
<h2>iGEM Columbia</h2>
 
<h2>iGEM Columbia</h2>
<p>Our iGEM team collaborated with Columbia University’s team to create an anonymous survey focused on understanding the perspectives people may have on specified treatments for illnesses. This was done to analyze the possible perceptions people may have concerning our treatments and the resulting products. The surveys were distributed primarily through an online format among individuals with differing factors such as age, gender, and educational background. To ensure responses relating to both teams’ projects, we decided to include questions that prompted individuals to consider different areas of treatment. Our team included questions pertaining to whether people would be willing to receive antimicrobial peptide treatments, while Columbia’s team included questions specifically relating to probiotic alternatives</p>
+
<p>Our iGEM team collaborated with Columbia University’s team to create an anonymous survey focused on understanding the perspectives people may have on specified treatments for illnesses. This was done to analyze the possible perceptions people may have concerning our treatments and the resulting products. The surveys were distributed primarily through an online format among individuals with differing factors such as age, gender, and educational background. To ensure responses relating to both teams’ projects, we decided to include questions that prompted individuals to consider different areas of treatment. Our team included questions pertaining to whether people would be willing to receive antimicrobial peptide treatments, while Columbia’s team included questions specifically relating to probiotic alternatives. The statistical analysis of this survey will provide insights on whether the attitudes toward receiving the treatments proposed by our team and iGEM Columbia differ among people of diverse demographics.</p>
 
</section>
 
</section>
  

Latest revision as of 01:16, 2 November 2017

Stony Brook 2017